Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Gynecology & Clinical Practices Volume 2 (2015), Article ID 1:IJGCP-107, 3 pages
http://dx.doi.org/10.15344/2394-4986/2015/107
Research Article
Carcinosarcoma (Malignant Mixed Muellerian Tumor) of the Ovary-A Single Institution Experience of 25 years

Edgar Petru*, Josef Haas, Sanja Beganovic, Vassiliki Kolovetsiou and Nora Woltsche

Department of Obstetrics and Gynecology, Medical University, Auenbruggerplatz 14, 8036 Graz, Austria
Dr. Edgar Petru, Department of Obstetrics and Gynecology, Medical University, Auenbruggerplatz 14, 8036 Graz, Austria; E-mail: edgar.petru@medunigraz.at
21 December 2014; 11 February 2015; 13 February 2015
Petru E, Haas J, Beganovic S, Kolovetsiou V, Woltsche N (2015) Carcinosarcoma (Malignant Mixed Muellerian Tumor) of the Ovary-A Single Institution Experience of 25 years. Int J Gynecol Clin Pract 2: 107. doi: http://dx.doi.org/10.15344/2394-4986/2015/107
© 2015 Petru et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Garg G, Shah JP, Kumar S, Bryant CS, Munkarah A, et al. (2010) Ovarian and uterine carcinosarcomas: a comparative analysis of prognostic variables and survival outcomes. Int J Gynecol Cancer 20: 888-894 [CrossRef] [Google Scholar] [PubMed]
  2. Athavale R, Thomakos N, Godfrey K, Kew F, Cross P, et al. (2007) The effect of epithelial and stromal tumor components on FIGO stages III and IV ovarian carcinosarcomas treated with primary surgery and chemotherapy. Int J Gynecol Cancer 17: 1025-1030 [CrossRef] [Google Scholar] [PubMed]
  3. Barakat RR, Rubin SC, Wong G, Saigo PE, Markman M, et al. (1992) Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases. Obstet Gynecol 80: 660-664 [Google Scholar] [PubMed]
  4. Hellström AC, Tegerstedt G, Silfverswärd C, Pettersson F (1999) Malignant mixed müllerian tumors of the ovary: histopathologic and clinical review of 36 cases. Int J Gynecol Cancer 9: 312-316 [CrossRef] [Google Scholar] [PubMed]
  5. Inthasorn P, Beale P, Dalrymple C, Carter J (2003) Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinum-based chemotherapy. Aust N Z J Obstet Gynaecol 43: 61-64 [CrossRef] [Google Scholar] [PubMed]
  6. Sreenan J, Hart W (1995) Carcinosarcomas of the female genital tract. A pathologic study of 29 metastastic tumors: Further evidence of the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 19: 666-674 [Google Scholar] [PubMed]
  7. Petru E, Lück HJ, Stuart G, Gaffney D, Millan D, et al. (2009) Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur J Obstet Gynecol Reprod Biol 143: 69-74 [CrossRef] [Google Scholar] [PubMed]
  8. Barnholtz-Sloan JS, Morris R, Malone JM Jr, Munkarah AR (2004) Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT). Gynecol Oncol 93: 506-512 [CrossRef] [Google Scholar] [PubMed]
  9. Brown E, Stewart M, Rye T, Al-Nafussi A, Williams AR, et al. (2004) Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer 100: 2148-2153 [CrossRef] [Google Scholar] [PubMed]
  10. Rauh-Hain JA, Diver EJ, Clemmer JT, Bradford LS, Clark RM, et al. (2013) Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis. Gynecol Oncol 131: 46-51 [CrossRef] [Google Scholar] [PubMed]
  11. Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, et al. (2013) Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med 58: 297-304 [Google Scholar] [PubMed]
  12. Asghar U, Imseeh G, Kirkwood A, Widschwendter M, Olaitan A, et al. (2014) 930P- A retrospective single institution study evaluating clinical outcome and prognostic markers for endometrial and ovarian carcinosarcomas. Ann Oncol [CrossRef] [Google Scholar]
  13. Cicin I, Saip P, Eralp Y, Selam M, Topuz S, et al. (2008) Ovarian carcinosarcomas: Clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum. Gynecol Oncol 108: 136-140 [CrossRef] [Google Scholar] [PubMed]
  14. Harris MA, Delap LM, Sengupta PS, Wilkinson PM, Welch RS, et al. (2003) Carcinosarcoma of the ovary. Br J Cancer 88: 654-657 [CrossRef] [Google Scholar] [PubMed]
  15. Rutledge TL, Gold MA, McMeekin DS, Huh WK, Powell MA, et al. (2006) Carcinosarcoma of the ovary-a case series. Gynecol Oncol 100: 128-132 [CrossRef] [Google Scholar] [PubMed]
  16. Ariyoshi K, Kawauchi S, Kaku T, Nakano H, Tsuneyoshi M (2000) Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases. Histopathology 37: 427-436 [CrossRef] [Google Scholar] [PubMed]
  17. Migalli C, Lima J, Della Pepa C, Kaye S, Gore M, et al. (2014) Ovarian carcinosarcoma management: A retrospective analysis of the royal Marsden experience. Ann Oncol 25: 902 [CrossRef] [Google Scholar]
  18. Silasi DA, Illuzzi JL, Kelly MG, Rutherford TJ, Mor G, et al. (2008) Carcinosarcoma of the ovary. Int J Gynecol Cancer 18: 22-29 [CrossRef] [Google Scholar] [PubMed]
  19. Zorzou MP, Markaki S, Rodolakis A, Kastritis E, Bozas G, et al. (2005) Clinicopathological features of ovarian carcinosarcomas: a single institution experience. Gynecol Oncol 96: 136-142 [CrossRef] [Google Scholar] [PubMed]
  20. Chang J, Sharpe JC, A'Hern RP, Fisher C, Blake P, et al. (1995) Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients. Ann Oncol 6: 755-758 [CrossRef] [Google Scholar] [PubMed]
  21. Lu CH, Chen IH, Chen YJ, Wang KL, Qiu JT, et al. (2014) Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: a Taiwanese Gynecologic Oncology Group Study. Int J Gynecol Cancer 24: 506-512 [CrossRef] [Google Scholar] [PubMed]
  22. Morrow CP, D’Ablaing G, Brady L, Blessing J, Hreshchyshyn MM (1984) A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A gynecologic oncology group study. Gynecol Oncol 18: 278-292 [CrossRef] [Google Scholar] [PubMed]
  23. Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R, et al. (2002) Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary. Gynecol Oncol 85: 459-463 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.